Autism-Open Access

Autism-Open Access
Open Access

ISSN: 2165-7890

Research Article - (2016) Volume 6, Issue 6

In Vivo Evaluation of the Antidepressant Activity of a Novel Polyherbal Formulation

Rinki Kumari Verma*
Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, India
*Corresponding Author: Rinki Kumari Verma, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, India, Tel: +07675948758 Email:

Abstract

Background: The present study was undertaken to evaluate the anti-depressive activity of a polyherbal formulation (PF) after 28 days administration by using a rat forced swimming test (FST) and tail suspension test (TST).

Methods: Animals were divided into six groups (n=6/group): Group 1: The control rats received injections of 0.5% CMC solution only; Group 2: FST+vehicle; Groups 3: FST+SER (10 mg/kg, i.p.); Group 4: FST+200 mg/kg; Group 5: FST+400 mg/kg; Group 6: FST+800 mg/kg and drugs were administrated once daily for 28 days treatment. To assess the effect of PF on immobility activity through FST and TST were used to take as a measure of antidepressant activity. The probable mechanism of action of the anti-depressive effect of PF was also investigated by measuring the level of serotonin, dopamine, norepinephrine, homocysteine, IL-2 and IFN-gamma levels in the blood of the stress rats.

Results: PF significantly reduced the immobility time of rat in both the FST and TST. However, might explain the results. In addition, PF decreased the homocysteine, IL-2 and IFN-gamma level while it increased the levels of serotonin, dopamine and norepinephrine in the blood. PF with 200 mg/kg treatment have shown the more significant improvement in stress rats.

Conclusion: After 28 days administration, PF produced antidepressant-like effects. The mechanisms of action of anti-depressive effect of PF seemed to involve an increase of the monoamines level while decreasing the inflammatory marker and homocysteine in the stress of rats.

Keywords: Depression; Antidepressant; Nyctanthes arbortristis; Hippophae salcifolia; Ocimum tenuiflorum; Reinwardtia indica; Forced swimming test; Tail suspension test; Neurochemicals; Homocysteine; Inflammatory marker

Introduction

Depression is the most prominent and a highly incapacitating neuropsychiatric disease [1]. World Health Organization (WHO) reported is the most burdensome diseases of society [2] and associated with miserable symptom and sign including mood, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, low energy and poor concentration. It is also a multifaceted disease with heterogeneous pathology [3]. Stress is involved in the dysfunction of hypothalamic-pituitary-adrenal axis (HPA) and nervous system along with the discrepancy of neurochemicals, neuro cytokine secretion and other biochemical [4-7]. Impairment of monoaminergic and neurotransmitter functions is also well-recognized factor in the etiology of depression [8,9].

Depression is also associated with a specific immunological state and imitative from the observation of so-called “sickness behavior”. Pro-inflammatory cytokines trigger sickness behavior [10]. Recent report have declared that increased pro-inflammatory cytokines, including interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α and interferon (IFN)-γ, significantly, involved in the succession of depression [11,12]. In course of depression, stress-induced alteration in the cytokine system is linked to genetic abnormalities, mRNA expression, intracellular, serum or saliva cytokine levels and neurotransmitter concentrations [13-16]. However, depression may dysfunction the immune system of the body.

Bottiglieri et al. reported that the elevated homocysteine (hcy) or hyperhomocysteinemia (Hhcy) level plays a significant role in the onset of neurodegenerative disorders (Alzheimer's and Parkinson’s disease) including several neuropsychiatric disorders (depression, schizophrenia and bipolar disorder). Hhcy indicated a failure of methylation of homocysteine to methionine due to a deficiency in the delivery of methyl groups from methyl folate [17]. Methionine is the immediate forerunner of S-adenosylmethionine (SAM), the methyl donor in innumerable methylation reactions in the synthesis of monoamines, neurotransmitters, nucleoproteins and membrane phospholipids. So, that the failure of one carbon metabolism in depression with folate deficiency associated with a high plasma homocysteine, was also accompanied by a significant fall in SAM [18-21].

New therapeutic products from the medicinal plant are used and progressed constantly, for the treatment of neuropsychiatric disorders. An increasing use of traditional medicine as antidepressant showed that traditional prescription drugs exhibited certain clinical efficacy, enhanced efficacy, reduced dosages and side effects of modern medicines. In the ancient traditional system of medicine, several single and polyherbal formulations (PF) are mentioned for the treatment of psychiatric disorders [22]. PF generally provide synergistic effect and help to minimize the adverse effects of the major drugs [23].

In the present study, we were prepared the first time this polyherbal formulation (PF) with the following composition with their bioactive molecules Nyctanthes arbortristis (Nyctanthic and Oleanolic acid), Hippophae salicifolia (Quercein, folic acid, flavonoids, Omega-7 and elagic acid), Ocimum tenuiflorum (α–terpinene and eugenol) and Reinwardtia indica (Linolenic acid and saponin). However, to date, the pharmacological effects and especially the antidepressant effect of this PF have not been established. Thus, we evaluated the antidepressant activity of this PF for Force Swim Test rats model (FST) to get a better understanding of this extract.

Although, animal stress models are widely used in the pre-clinical evaluation of antidepressants. The behavioral despair tests (forced swim and tail suspension test) were developed using rats for the development of antidepressant drugs [24,25]. Since then it has become one of the most widely used tests for antidepressant screening [26,27].

Moreover, we determined whether the alteration of biogenic amines [Serotonin (5HT), Dopamine (DA)] and homocysteine (Hcy) might predict the antidepressant properties of PF. We evaluated the effect of PF on the immune system by measuring alterations in serum inflammatory markers like interleukin-2 (IL-2), Interferon gamma (IFN-Y) which is involved in the rats FST model of depression.

Materials and Methods

Animals

The experiments were performed on healthy albino Wistar rats (AW) (150-200 g) of both sexes procured from Animal Central House, Institute of Medical Science, Banaras Hindu University, Varanasi, India. The rats were kept in plastic cages with paddy husk as bedding in the animal house with a regulated ambient temperature of 23 ± 2ºC, a relative humidity of 30–70% with a 12 h/12 h light dark cycle and had free access of food with water ad libitum. The experiments were carried out between 10.00 to 5.00 h and animals were allowed to acclimatize to the laboratory conditions for 7 days prior to dosing. The water used to be always double distilled. The animals were used only once for each experiment. The experimental studies were performed in accordance with the Guide for the care and use of laboratory animals, as adopted and promulgated by the Institutional Animal Care Committee of Institute of Medical Science, Banaras Hindu University (reference number; ECR/526/Inst/UP/2014Dt.31.1.14).

Plant collection and identification

Dubey NK, was identified and authenticated the leaves of N. arbortristis , fruits and leaves of H. salicifolia , whole plant of O. tenuiflorum and roots of R. indica . These plants were collected from forests of India and fruits and leaves of H. salicifolia were collected from Himachal Pradesh (Leh and Laddakh) respectively. The voucher specimens of the plants have been deposited (Accession No: SH-2010, LH-2008, SH-2008 and SH-2008) in the herbarium for further reference.

Extraction of the plant material

The shed dried leaves of N. arbortristis, fruits and leaves of H. salicifolia , whole plant of O. tenuiflorum , seeds and roots of R. indica were used for the preparation of extracts. The shade dried and powdered plant materials (500-700 g) were extracted with ethanol (70%) by a cold extraction process. The extract was then concentrated in-vaccuo and the yield percent was calculated (Table 1). Extracts were stored at 4°C until use.

S. No. Plant Percentage yield
70% ethanol
1 Nyctanthes arbor-tristis 0.91-2.11
2 Ocimum tenuiflorum 0.84-0.98
3 Hippophae salicifolia 1.22-1.27
4 Reinwardtia indica 0.98-2.03

Table 1: The concentration of the major phyto-constituents in the extracts depends on the percentage yield of the hydro alcoholic extracts of PF.

Drugs, reagents and drug administration

Sertraline hydrochloride (SER), a SSRI antidepressant, was gifted from Pharmaceutical Company, Badi, Punjab and was used as standard drug for antidepressant effect. PF has been prepared in this composition: Nyctanthes arbortristis-75 mg/kg, Hippophae salicifolia -50 mg/kg, Ocimum tenuiflorum -40 mg/kg and Reinwardtia indica -35 mg/kg and all drugs were dissolved in 0.5% Carboxyl Methyl cellulose (CMC). All the chemicals used were of analytical grade from standard companies.

The effects of drug administration were examined on the total duration of immobility for the rats during the FST. Rats were administered with SER and PF, 60 min before the test swim session [28]. SER was administered intraperitoneal in a volume equivalent to 2 ml/kg. PF were each given orally by gavages and the drug solutions were freshly prepared each morning. Doses were calculated as mg/kg of base and determined as described previously [29].

The 36 AW rats were equally and randomly assigned in to six groups- Group 1: The control rats received injections of 0.5% CMC solution only; Group 2: FST+vehicle, Groups 3: FST+SER (10 mgkg−1, i.p.); Group 4: FST+200 mg/kg; Group 5: FST+400 mg/kg Group 6; FST+800 mg/kg.

Drugs were administrated once daily for 28 consecutive days to animals. Forced swimming was used to induce stress in rats and has shown the alterations in biogenic amines, neurocytokine and homocysteine, etc. The method for stress was similar to FST below [24,30]. All the groups of rat were subjected to a swimming test except group I.

Behaviour despair study

Immobility time measured by forced swim test (FST)

The FST is the most widely used pharmacological models for assessing antidepressant activity and was performed according to the method described by Porsolt with slight modifications [31]. FST was consisted of two parts; an initial training period of 15 min and an actual test for 5 min after 24 h. Rats were exposed to forced swimming stress daily for a duration of 5 min between 11.00 AM to 12.00 AM till 28 days. During training rats were placed in the glass jar for the first time the rats were initially highly active, vigorously swimming in circles, and trying to climb the wall or diving to the bottom. After 2–3 min, their activity began to subside and was interspersed with phases of immobility or floating of increasing length. After 5–6 min, immobility reached a plateau where the rat remained immobile for approximately 80% of the time. After 15 min in the water, the rats were removed, wiped with a dry cloth and allowed to dry before being returned to their home cages. The glass jar was emptied and washed thoroughly after testing for each rat. The rats were again placed in the jar 24 h later, after initial administration of the SER and PF and their activity was recorded within 5 min. The time spent performing the behaviour alteration test was measured using a video camera.

Tail suspension test (TST)

Tail suspension induced the immobility was measured According to Steru et al. [32]. This is a simple, rapid and reliable method to screen antidepressants. In this method rat were suspended above the floor by adhesive tape placed approximately 1-2 cm from the tip of the tail and shows alternate agitation and immobility which is indicative of a state of depression. The remained immobile time of TST was quantified for 6 min. Rats were considered immobile only when they hung passively and completely motionless.

Blood collections

The animals were sacrificed by cervical dislocation immediately after FST. A total of 10 mL of blood was withdrawn immediately from orbital puncher from all groups, occurred during the light phase. Divided the blood sample in to two parts. One was collected in potassium (K2) ethylene diamine tetra acetic acid (EDTA)-coated tubes and other in plan tube. Blood sample of EDTA coated tubes was centrifuged (2000 rpm) at 4°C for 20 min and separated the plasma. It was collected and dispensed into 1.5 ml eppendorf tube and stored at – 80°C until assay. For serum, blood samples were left to clot for 2 h prior to centrifugation for 15 min at 4000 rpm.

Quantification of serotonin, dopamine, norepinephrine, homocysteine, IL-2 and IFN-gamma

Serotonin and IFN gamma were estimated in serum using by available kit enzyme-linked immunosorbent assay (Cata. No. KA1894; Cata. No.NBP1-92680). Dopamine, norepinephrine, homocysteine and IL-2 in plasma were also quantified by ELISA (Cata. No. KA1887; Cata. No. KA1891; Cata. No. KA1242 and Cata. No. KA0986, respectively). Plasma samples were thawed on ice and further processed according to manufacturer’s instructions). All ELISA kits from Novus Biologicals a biotech brands.

Statistical analysis

All data are expressed as mean ± standard error of the mean (SEM). Data was analyzed using a statistical package (Statistical Package for the Social Sciences (SPSS). FST immobility time, monoamines, homocysteine and cytokine data were analyzed by one-way analysis of variance (ANOVA) with drug administration. If the P value is less than 0.05, the difference was considered statistically significant.

Results

Effects of the hydro-alcoholic extract of PF and sertraline on immobility time in the rat FST

Force Swim stress (FSS) significantly increased the immobility period as compared to control rats. The clinically effective antidepressant drug Sertraline hydrochloride (10 mg/kg, ip) administered for 28 successive days significantly decreased the immobility period in stressed rats as compared to the stress controls. Whereas when compared to healthy control, it was non-significant. As like this the hydro-ethanolic extract of PF at 200, 400 and 800 mg/kg significantly reduced the duration of immobility (F=92.75, P<0.001), when orally administered for 28 days. We observed the maximal antidepressant action by PF was obtained at a dose of 200 mg/kg, resulting in 54.24% immobility reduction. PF, produced a marked reduction in immobility time and there was a significant effect of the PF administration for the immobility time in the FST as seen in Figure 1.

autism-alcoholic-extract

Figure 1: Effects of the hydro alcoholic extract of PF at 200, 400 and 800 mg/kg, Sertraline at 10 mg/kg on the immobility time in the stressed rats FST. *P<0.05, **P<0.01, ***P<0.001 in comparison to model animals treated with control.

Effect of PF and sertraline on immobility periods of rat in TST

FS significantly increased the immobility period as compared to vehicle-treated unstressed rat. Sertraline (10 mg/kg, ip) administered for 28 successive days significantly (P<0.001) decreased the immobility period in stressed rats as compared to the unstressed and stressed controls. PF (200, 400, 800 mg/kg) orally administered for the same days to stressed rats and show highly significant effect on immobility period (F=143.40, P<0.001) the immobility period in stressed rat as compared to its stress and unstressed control (Figure 2).

autism-hydro-alcoholic

Figure 2: Effects of the hydro alcoholic extract of PF at 200, 400 and 800 mg/kg, Sertraline at 10 mg/kg on the immobility time in the stressed rats TST. For statistical significance *P<0.05, **P<0.01,***P<0.001 in comparison to TST model animals treated with control.

Effects of the hydro-alcoholic extract of PF and sertraline in serotonin (5-HT), dopamine (DA) and norepinephrine (NE)

The effects of the hydro-alcoholic extract of PF and Sertraline after 28 repeated day treatments in the monoamine neurotransmitter levels in the rat FST were shown in Table 2. Significant decreases in serotonin (5-HT), dopamine (DA) and norepinephrine (NE) levels in rats were observed after swim stress (5-HT: F=32.54, P<0.01; DA, F=142.59, P<0.001; NE, F=54.46, P<0.001) as compared to respective healthy control (Table 2).

Hydro-alcoholic extract of PF (200,400 and 800 mg/kg) produced a significant (p<0.001, p<0.01, p<0.01) increase in 5HT levels in rat as compared to its control. Sertraline did not significantly increase, but markedly elevated the 5HT in rat, when compared with its control. On the other hand, the hydro alcoholic extract was significantly attenuated swim stress induced increase in 5HT level in rat. The maximal effect was obtained at 200 mg/kg which showed highly significant. PF was also attenuated the decrease in brain DA levels induced by swim stress, the maximal effect value being 200 mg/kg (P<0.001). The extract at 400 and 800 mg/kg reversed the decreased levels of the normal value. Sertraline was also significantly altered the DA levels (Table 2).

Similarly, swim stress markedly reduced NE levels (F=54.46, P<0.001) whereas we were observed PF to elicit an increase NE levels. The maximal effect value being 200 mg/kg, which return the swim stress-induced decrease in NE levels to the normal value. However, Sertraline failed to significantly change the swim stress-induced decrease in NE levels (P=0.06) (Table 2).

Effect of PF and sertraline in the level of homocysteine (Hcy)

Force stress resulted in significant (p<0.001) increase in Hcy level as compared to vehicle-treated unstressed rat. PF (200, 400 and 800 mg/kg) and Sertraline (10 mg/kg) per se administered for 28 consecutive days significantly reduced Hcy level in rat (p<0.001, p<0.01, p<0.01and p<0.01; p<0.001, respectively) in the rat whose stressed by force swims as compared to control rats. Chronic treatment with PF (200, 400 and 800 mg/ kg) and Sertraline (10 mg/kg) markedly reduced the level of both inflammatory markers (Table 2).

Sertraline failed to significantly decrease IL2 levels (p<0.36) whereas PF (200, 400 and 800 mg/kg) per se produced a significant (p<0.001, p<0.05 and p<0.05, respectively) decrease in the IL2 levels in stressed rats as compared to respective control (Table 2).

IFN-Y levels were increased significantly (p<0.001) after chronically stressed rats as compared to control rats. Chronic treatment with PF (200, 400 and 800 mg/ kg) and Sertraline (10 mg/kg) per se produced a significant (p<0.001) reduction in IFN-Y levels in the stressed rat as compared to the respective controls. However, PF was showed a greatly significant decrease IFN-Y level in rat as compared to their respective control groups (Table 2).

Group Monoamine (pg/ml) neurotransmitter levels Pro-inflammatory marker (pg/ml) Homocysteine (µ mol/)
5HT DA NE IL-2 IFN-Υ
CMC 952.5 ± 3.8 1277.9 ± 6.2 389.6 ± 6.0 0.2 ± 0.01 15.7 ± 1.0 3.9 ± 0.2
FST+Vehcile 566.1 ± 6.8*** 946 ± 18.3** 262.1 ± 9.8*** 1.6 ± 0.2* 29.9 ± 0.2** 9.1 ± 0.2***
FST+SER 852.9 ± 50.2 1259 ± 8.0*** 363.9 ± 1.3 0.3 ± 0.01* 19.5 ± 0.4** 5.3 ± 0.1*
FST+200 mg/kg 841.8 ±17.0*** 1214.1 ± 17.1*** 362.9 ± 4.4** 0.3 ± 0.01* 17.2 ± 1.5*** 5.6 ± 0.2***
FST+400 mg/kg 710.2 ± 22.49* 1100.5 ± 1.3* 317.6 ± 2.9* 0.3 ± 0.02* 23.8 ± 0.2* 6.4 ± 0.2**
FST+800 mg/kg 687.8 ± 14.2* 1027 ± 5.3* 326.7 ± 6.1* 0.4 ± 0.02* 21.8 ± 0.3* 6.4 ± 0.1*

Table 2: Effects of the hydro alcoholic extract of PHF at 200,400 and 800 mg/kg, Sertraline at 10 mg/kg on monoamine neurotransmitter levels, pro-inflammatory and homocysteine in the rat FST. For statistical significance *P<0.05, **P<0.01, ***P<0.001 in comparison to FST model animals treated with control

Discussion

The present study showed that administration of the hydroalcoholic extract of PF could normalize behavioral, monoamines, homocysteine and neurocytokine alterations induced by swimming stress. These findings confirmed antidepressant-like effects of the hydro-alcoholic extract of PF through neurochemicals, homocysteine and neurocytokine mechanisms.

Ancient medicine is widely held to beneficial but generally neither the active principles nor their molecular targets are well defined [33], therefore, an understanding of the active component(s) and the mechanism(s) of action can make such medicines more acceptable. The present polyherbal formulation (PF) was prepared by following composition- Nyctanthes arbortristis, Hippophae salicifolia, Ocimum tenuiflorum and Reinwardtia indica.

Nyctanthes arbortristis (family Oleaceae), is used as a medicinal plant owing to its numerous medicinal properties. In Ayurveda, its leaves used for the improvement of memory, treatment of nervous system disorders, hypnotic, tranquilizing and local anaesthetic activities. It is possessing anti-depressant, anti-convulsive activity, improvement of memory and CNS depressant action [34,35]. Due to contain of several bioactive molecules like mannitol, glucose, essential oil, carotene, β-amyrin, β-sitosterol, hentriacontane, benzoic acid, triterpenoid (oleanolic acid, nyctanthic acid, friedeline, lupeol tannic acid, ascorbic acid, methyl salicylate, an amorphous glycoside) and iridoid glycosides (arborsides A, B, C) [36].

Hippophae salicifolia (family Elaeagnaceae) also known as seabukthron (SBT), is used in traditional Chinese medicine since the Tang Dynasty, going back more than 1000 years. This plant is a deciduous and medicinal tree with great nutritional value. Its berries have several bioactive such as cerebroside, oleanolic acid, ursolic acid, 19-alpha-hydroxyursolic acid, dulcioic acid, 5-hydroxymethyl-2- furancarbox-aldehyde, cirsiumaldehyde, octacosanoic acid, palmitic acid and 1-O-hexadecanolenin with a wide range of pharmacological activities including antioxidant, immuno-modulatory, antiatherogenic, anti-stress, hepatoprotective, radioprotective, and tissue repair properties [37,38]. The berries have preventive effects against cardiovascular diseases, mucosa injuries, skin problems, cancer and altered immune system function [39].

Ocimum tenuiflorum (family Lamiaceae) in Ayurveda has been used for wide range of pharmacological activity such as adaptogenic, anti-asthmatic, anti-oxidant, COX-2 inhibitor and anti-inflammatory because of presence of core chemical constituents like eugenol, oleanolic acid, ursolic acid, rosmarinic acid, etc., Eugenol, (4-9%) Carvacrol, Linalool, β-Caryophyllene 8%, β –elemene, 11%, Germacrene D 2%, β –bisabolene 13-20%, Methyl chavicol 3-19%, 1-8 cineol 9-33%, α-bisabolene, α-terpineol. Due to the presence of high concentration of eugenol, it is used as anti-analgesic, antihyperlipidemic and showed cardioprotective effects, promotes immune system function and involved in cell repairing [40,41].

Reinwardtia indica (basanti) belongs to the Linaceae family and is found in the Himalayan range [42], traditionally used in the treatment of paralysis, wounds, cuts, boils and carbuncle [43-45]. The hydroalcoholic extract of the leaves has anti-bacterial and anti-oxidant (nitric oxide radical scavenging activities) properties in vitro [42].

Numerous studies have shown force swims induced depression model can be used for evaluating the potential antidepressants by employing behavioural tests like FST and TST. FST and TST are commonly used behavioural despair models in rodents to predict antidepressant potential by measuring the decrease in immobility periods and both are valuable for probing the mechanism of depression [24,25,32]. Induction of depression using force swim stress is considered as the most valid animal model of depressive behavior observed in humans after a long-term exposure to multiple stressor [24,25,32].

In the present study, rat that was exposed to stress, exhibited greater immobility periods in the FST and TST as compared to healthy control animals, thus showed depression-like behaviour. Sub-chronic treatment with SER (10 mg/kg, ip) or PF (200, 400, 800 mg/kg, oral) produced a significant decrease in immobility periods of stress rat in the FST and TST, indicating significant antidepressant-like activity. However, in the forced swim stress AW rat, the hydro-alcoholic extract of PF produced a significant reduction in immobility time when orally administered for 28 consecutive days. In addition, the compounds enhancing mobility activity may give rise to a false positive effect in the stress rat. Thus, antidepressant-like activity of PF in stressed rats is specific. PF caused a reduction in the immobility time in FST and TST (Figures 1 and 2, respectively,). The results presented here show, to our knowledge for the first time, that PF given orally is effective in producing significant antidepressant-like activity, when assessed in the FST and TST. In both tests, anti-depressants can also be distinguished from stimulants, because stimulants cause marked motor stimulation, in contrast to antidepressants, which do not [1,26].

A moment ago clinically employed antidepressants exert their effects predominantly on monoaminergic system [1,3], cytokine [46-49] and homocysteine [21,50-52] although it is unlikely that pharmacological manipulation of a neurotransmitter in relative isolation would produce changes sufficient to remedy severe neurochemicals dysfunction and other biochemical [1-3]. Numerous evidence from anatomical, electrophysiological and pharmacological studies that the interactions between neurotransmitter and other biochemical systems are imperative in depression [26]. Monoamine neurotransmitters, including 5-HT, NE and DA play important roles in depression and in mediating behavioural effects of antidepressant drugs. Abnormal monoamine levels in the FSS rat may be relevant to the depressed state. Force swims stress produced the reductions in 5- HT, NE and DA in AW rat. Of great interest were the results showing that the hydro-alcoholic extract of PF clearly elevated the decreased monoamine neurotransmitter levels induced by swim stress. As shown in Table 2, PF (200, 400 and 800 mg/kg, p.o) increased the level of 5- HT, NE and DA in stressed rats, whereas 200 mg/kg, p.o. PF increased the level of 5-HT, NE and DA. These results indicated that the effect of PF on depression may be mediated via the increase in monoamines levels in rats. These findings suggested that antidepressant-like effects of the hydro alcoholic extract of PF were mediated through the modulation of serotonergic and norepinephrinegic neurotransmission, as well as dopaminergic neurotransmission.

Evidences from both clinical and preclinical studies support that there may be an impairment of inflammatory immune function in depression [53,54]. The most frequently occurring cytokine abnormality in depressed subjects is hyperactivity of the Hypothalamic-Pituitary-Adrenal (HPA) axis characterized by glucocorticoids. Stress leads to habituation of the HPA axis response and thus impairs the delayed-type hypersensitivity' (DTH) response. [55,56].

Several types of psychological stressors can induce an alteration in neurotransmitter including disturbed functioning of the adaptive immune system, as well as T and B lymphocytes and innate immune cells, particularly natural killer (NK) cells and macrophages. As a result, stress stimuli lead to a variety of changes in the function, shape, signalling and proliferative capacity of neuronal cells. It can also cause decreases in neurogenesis, compressed the hippocampus and impaired the structural neuronal plasticity [57-60].

The ‘cytokine hypothesis of depression’ demonstrated that psychosocial stressors and internal stressors raised secretion of proinflammatory cytokines are supposed to increase the risk of developing depression. More than a little evidence supported the elevations of the pro-inflammatory cytokines such as interleukin (IL)-1, IL-2, IL-6, interferon-g (INF-g) and tumor necrosis factor-a (TNF-a), play a vital role in the progression of depression [61-63].

Molecular mechanisms may contribute to cytokine involvement in the progression of depression. Various stressors raised proinflammatory cytokines which stimulate the activity of indolamine-2,3-dioxygenase (IDO) is an enzyme metabolizing tryptophan (act as precursor of serotonin and melatonin) to kynurenine. IDO stimulation increased synthesis of the potent neurotoxic metabolites kynurenine and quinolinic acid and ultimately, reduced synthesis of neurotransmitters [64]. During mechanism raised cytokines trigger up-regulation of serotonin reuptake transporters by increasing gene expression and potentially leading to more rapid reuptake of serotonin from the synaptic cleft [65]. However, cytokine may contribute to dysregulation of the hypothalamo-pituitaryadrenocortical (HPA) axis in depression [66,67] by a state dependent effect on the secretion of adrenocorticotropic hormone (ACTH), cortisol and microglial cells. As result cytokine induced serotonergic dysfunctions by regulating serotonin transporter activity [13,14,68].

Various reports have supported that action of antidepressants may involve U-turn the effects of stress through direct regulation of synaptic architecture, dendritic morphology and survival of neurons and its treatments exert positive actions on the cellular processes. These studies have focused on the hippocampus and future work will be required to determine the influence of antidepressants on cell survival in prefrontal cortex and other brain regions [69].

Taken together, we may speculate that the effects of the hydro alcoholic extract of PF may produce on inflammation and proinflammatory cytokines may contribute to its amelioration on the serotonergic dysfunctions and the impaired feedback inhibition of the HPA axis. Finally contribute to its maintenance of hippocampal morphologic and functional plasticity. In the present study, our findings have shown that the antidepressant-like effects of PF are associated with lowering the level of IL-2 and IFN gamma. Thus, the subtle network and the precise role of each component warrant further explorations. In the present study, our finding has shown PF, acts as an herbal antidepressant, exerts extensive anti-inflammatory activities including the inhibitory activity on IL-2 and IFN gamma. PF with these doses 200, 400 and 800 mg/kg have shown anti-inflammatory indicating that this effect was concomitance with decreases the level of pro-inflammatory marker (IL-2 and IFN gamma). Therefore, we may speculate that the anti-inflammatory effect of these hydro-alcoholic extract is possibly related to their antidepressant-like effect. Our finding suggested that the PF could be beneficial in stress related psychiatric disorders associated with an over activity of the HPA axis system.

As various report hcy is a pro-inflammatory or non-proteogenic sulfur containing redox active endogenous amino acid, derived from dietary methionine through demethylation and can be re-methylated to methionine (precursor of S-adenosylmethionine (SAM)) via the remethylation or by the action of metabolic enzymes and cofactors [50]. The synthesis of methionine from homocysteine requires a transfer of CH3 groups from methyl folate and also vitamin B12 as a cofactor. As available report methionine is in turn the instant precursor of SAM. The methylation reactions are essential for the synthesis of monoamines, neurotransmitters, proteins, nucleoproteins, and membrane phospholipids [18].

Various studies have shown higher plasma hcy is a sensitive marker of functional deficiency of either folic acid or vitamin B12. Many types of stress may impair the metabolism of hcy which caused HHcy that raised the neurotoxic effects in the pathogenesis of depression [69]. Previously, reported that stress inhibited synaptic transmission at the neuromuscular junction, targeting primarily the motor nerve terminals [70]. However, Hhcy is indicates a failure of methylation of hcy to methionine due to a shortage of supply of methyl groups from methyl folate or, more rarely in depression. Folate deficiency associated with the significant fall in SAM and effects on mood [69,71].

In short, PF have major effective constituents such as nyctanthic, oleanolic acid, elagic acid, flavonoids, folic acid, quercein, tocopherols, ursolic acid, α–terpinene,eugenol, rosmarinic and saphonin [34-42]. Thus, PF have shown their action on various targets involved with depression like monoamine content, pro-inflammatory markers, behavioural pattern and oxidative marker, etc. We hypothesized that PF could be effective in the management of depression or disease caused by imbalance of neurotransmitter, inflammatory and oxidative stress. Our present study can be summarized by following finding:

1. The force swim stress procedure caused depressive-like behaviour in treatment rats, as observed by different behaviour despaired test like FST and TST.

2. Significant reduction in depressive-like behaviours was evident in the stressed rats treated with PF and SER.

3. Forced swim test procedures imbalance the neurotransmitter along with oxidative damage by increasing hcy in the treated rats.

4. PF and SER treatments exerted protective effects against forced swim stress and increase the level of neurotransmitter and decrease the hcy and inflammatory marker in the rat.

However, PF with 200 mg/kg treatment have shown the significant improvement and reduced the level of hcy. In our present study, PF may take up the re-methylation reaction for the synthesis of methionine and it is involved in enhancing the concentration of neurotransmitter in stressed rat through the augment the synaptic transmission at the neuro-junction and motor nerve terminals.

Conclusion

In conclusion, our data indicated that low-dose of PF had an antidepressant activity effect on force swim stress induced depression model rats. The behavioral indicators improved compared with model group. We found that 5HT, DA and NE level in serum and plasma, respectively, were significantly increased as compared with the model group by ELISA. Thus, we confirmed that PF has antidepressant activity, its mechanism may be related to the decreased levels of proinflammatory cytokines (IL-2 and IFN gamma) activity, regulating the function of the HPA axis, and inhibiting glucocorticoid receptor expression. The hydro-alcoholic extract of PF suppressed the level of plasma hcy in stressed rat. Lowering effect of PF may restart the remethylation and increased the concentration of neurotransmitter.

Acknowledgement

The authors would like to thank Adesh University Punjab and SRM, Chennai for their assistance and support.

References

  1. Liao JC, Tsai JC, Liu CY, Huang HC, Wu LY, et al. (2013) Antidepressant-like activity of turmerone in behavioral despair tests in mice. BMC Complement Altern Med 13: 299.
  2. Dang H, Chen Y, Liu X, Wang Q, Wang L, et al. (2009) Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Prog Neuropsychopharmacol Biol Psychiatry 33: 1417-1424.
  3. Yi LT, Xu HL, Feng J, Zhan X, Zhou LP, et al. (2011) Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin. Physiol Behav 102: 1-6.
  4. Esch T, Stefano GB, Fricchione GL, Benson H (2002) The role of stress in neurodegenerative diseases and mental disorders. Neuro Endocrinol Lett 23: 199-208.
  5. Alfonso J, Frasch AC, Flugge G (2005) Chronic stress, depression and antidepressants: Effects on gene transcription in the hippocampus. Rev Neurosci 16: 43-56.
  6. Sartori SB, Whittle N, Hetzenauer A, Singewald N (2012) Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment. Neuropharmacology 62: 304–312.
  7. Chen Y, Andres AL, Frotscher M, Baram TZ (2012) Tuning synaptic transmission in the hippocampus by stress: The CRH system. Front Cell Neurosci 6: 13.
  8. Delgado PL (2000) Depression: The case for a monoamine deficiency. J Clin Psychiatry 61 Suppl 6: 7-11.
  9. Chuang CY, Shi YC, You HP, Lo YH, Pan TM (2011) Antidepressant effect of GABA-rich monascus-fermented product on forced swimming rat model. J Agric Food Chem 59: 3027-3034.
  10. Dantzer R (2009) Cytokine, sickness behavior and depression. Immunol Allergy Clin North Am 29: 247-264.
  11. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, et al. (1995) Cytokine production and serum proteins in depression. Scand J Immunol 41: 534-538.
  12. Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H (2013) Cytokines as biomarkers in depressive disorder: Current standing and prospects. Int Rev Psychiatry 25: 592-603.
  13. Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, et al. (2008) Depression, comorbidities and the TNF-alpha system. Eur Psychiatry 23: 421-429.
  14. Himmerich H, Milenović S, Fulda S, Plümäkers B, Sheldrick AJ, et al. (2010) Regulatory T cells increased while IL-1β decreased during antidepressant therapy. J Psychiatr Res 44: 1052-1057.
  15. Bernberg E, Ulleryd MA, Johansson ME, Bergström GM (2012) Social disruption stress increases IL-6 levels and accelerates atherosclerosis in ApoE-/-mice. Atherosclerosis 221: 359-365.
  16. Jaremka LM, Lindgren ME, Kiecolt-Glaser JK (2013) Synergistic relationships among stress, depression and troubled relationships: Insights from psychoneuroimmunology. Depress Anxiety 30: 288-296 .
  17. Bottiglieri T, Laundy M, Crellin R, Toone MK, Carney MWP, et al. (2000) Homocysteine, folate, methylation and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 69: 228–232.
  18. Reynolds EH, Carney MW, Toone BK (1984) Methylation and mood. Lancet 2: 196-198.
  19. Baldessarini RJ (1987) Neuropharmacology of S-adenosyl-L-methionine. Am J Med 83: 95-103.
  20. Crellin R, Bottiglieri T, Reynolds EH (1993) Folates and psychiatric disorders. Clinical potential. Drugs 45: 623-636.
  21. Bottiglieri T, Hyland K, Reynolds EH (1994) The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 48: 137-152.
  22. Bhattacharya SK (1994) Behavioural studies on BR-16A (Mentat), an herbal psychotropic formulation. Indian J Exp Biol 32: 37-43.
  23. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 229: 327–336.
  24. Porsolt RD, Bertin A, Jalfre M (1978) "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51: 291-294.
  25. Borsini F, Meli A (1998) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94: 147–160.
  26. Petit-Demouliere B, Franck C, Michel B (2005) Forced swimming test in mice: A review of antidepressant activity. Psychopharmacology 177: 245–255.
  27. Mancinelli A, D'Aranno V, Borsini F (1987) Lack of relationship between effect of desipramine on forced swimming test and brain levels of desipramine or its demethylated metabolite in rats. Psychopharmacology (Berl) 92: 441-443.
  28. Watanabe H, Kobayashi T, Tomii M, Sekiguchi Y, Uchida K, et al. (2002) Effects of Kampo herbal medicine on plasma melatonin concentration in patients. Am J Chin Med 30: 65-71.
  29. Nanjappa K, Shalam M, Harish M, Prabhu S, Kutty B (2006) Pharmacological and neurobiochemical evidence for antidepressant like effect of sumind, a herbal product in animals. The Internet Journal of Nutrition and Wellness 4: 1.
  30. Millan MJ (2006) Multi-target strategies for the improved treatment of depressive states? Conceptual foundations and neuronal substrates. Drug Discovery and Therapeutic Application 110: 135–370.
  31. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367-370.
  32. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, et al. (2007) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28: 1765–1773.
  33. Das S, Sasmal D, Basu SP (2008) Evaluation of CNS depressant activity of different plant parts of Nyctanthes arbortristis Linn. Indian J Pharm Sci 70: 803-806.
  34. Deshmukh VK, Juvekar AR (2006) Anti-stress, antianxiety and nootropic activity of Nyctanthes arbortristis leaves. Planta Medica 72.
  35. Agrawal J, Pal A (2013) Nyctanthes arbor-tristis Linn--a critical ethnopharmacological review. J Ethnopharmacol 146: 645-658.
  36. Beveridge T, Li TS, Oomah BD, Smith A (1999) Sea buckthorn products: Manufacture and composition. J Agric Food Chem 47: 3480-3488.
  37. Kallio H, Yang B, Tahvonen R, Hakala M (2000) Composition of sea buckthorn berries of various origins. In: Proceedings of international workshop on sea buckthorn. China Beijing 13–19.
  38. Negi PS, Chauhan AS, Sadia GA, Rohinishree YS, Ramteke RS (2005) Antioxidant and antibacterial activities of various seabuckthorn (Hippophae rhamnoides L.) seed extracts. Food Chem 92: 119–124.
  39. Geetha RK, Vasudevan DM (2004) Inhibition of lipid peroxidation by botanical extracts of Ocimum sanctum: In vivo and in vitro studies. Life Sci 76: 21-28.
  40. Williamson EM (2002) Major herbs of Ayurveda. Churchill Livingstone, London.
  41. Shukla A, Vats S, Shukla RK (2013) Preliminary phytochemical screening, antibacterial and nitric oxide radical scavenging activities of Reinwardtia indica Leaves Extract. Int J PharmTech Res 5.
  42. Verma S, Chauhan NS (2007) Indigenous medicinal plants knowledge of Kunihar forest division, district Solan. Indian Journal of Traditional Knowledge 6: 494-497.
  43. Pande PC, Tiwari L, Pande HC (2007) Ethnoveterinary plants of Uttaranchal –A review. Indian Journal of Traditional Knowledge 6: 444-458.
  44. Li S, Wang C, Li W, Koike K, Nikaido T, et al. (2007) Antidepressant-like effects of piperine and its derivative, antiepilepsirine. J Asian Nat Prod Res 9: 421-430.
  45. Sharpley CF, Agnew LL (2011) Cytokines and depression: Findings, issues and treatment implications. Rev Neurosci 22: 295-302.
  46. Han QQ, Yu J (2014) Inflammation: A mechanism of depression? Neurosci Bull 30: 515-523.
  47. Brites D, Fernandes A (2015) Neuroinflammation and depression: Microglia activation, extracellular microvesicles and micro RNA dysregulation. Front Cell Neurosci 17: 476.
  48. Pinto EF, Andrade C (2016) Interferon-related depression: A primer on mechanisms, treatment and prevention of a common clinical problem. Curr Neuropharmacol 14: 743-748.
  49. Bukharaeva E, Shakirzyanova A, Khuzakhmetova V, Sitdikova G, Giniatullin R (2015) Homocysteine aggravates ROS-induced depression of transmitter release from motor nerve terminals: potential mechanism of peripheral impairment in motor neuron diseases associated with hyperhomocysteinemia. Front Cell Neurosci 9: 391.
  50. Bhatia P, Singh N (2015) Homocysteine excess: Delineating the possible mechanism of neurotoxicity and depression. Fundam Clin Pharmacol 29: 522-528.
  51. Kumari R, Agrawal A, Singh GPI, Dubey GP (2015) Hyperhomocysteinemia as risk factor for depression: A review. Pharmaceutical and Biological Evaluations 2: 133-141.
  52. Castanon N, Leonard BE, Neveu PJ, Yirmiya R (2002) Effects of antidepressants on cytokine production and actions. Brain Behav Immun 16: 569-574.
  53. Capuron L, Miller AH (2011) Immune system to brain signaling: Neuropsychopharmacological implications. Pharmacol Ther 130: 226-238.
  54. McEwen BS (2000) The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886: 172-189.
  55. Dhabhar FS (2000) Acute stress enhances while chronic stress suppresses skin immunity. The role of stress hormones and leukocyte trafficking. Ann N Y Acad Sci 917: 876-893.
  56. Rosenbrock H, Koros E, Bloching A, Podhorna J, Borsini F (2005) Effect of chronic intermittent restraint stress on hippocampal expression of marker proteins for synaptic plasticity and progenitor cell proliferation in rats. Brain Res 1040: 55–63.
  57. Radley JJ, Rocher AB, Miller M, Janssen WG, Liston C, et al. (2006) Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cereb Cortex 16: 313–320.
  58. Dagyte G, Van der Zee EA, Postema F, Luiten PG, Den Boer JA, et al. (2009) Chronic but not acute foot-shock stress leads to temporary suppression of cell proliferation in rat hippocampus. Neuroscience 162: 904-913.
  59. Chen Y, Andres AL, Frotscher M, Baram TZ (2012) Tuning synaptic transmission in the hippocampus by stress: The CRH system. Front Cell Neurosci 6: 13.
  60. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, et al. (2009) The inflammatory and neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression. Metab Brain Dis 24: 27-53.
  61. Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H (2013) Cytokines as biomarkers in depressive disorder: Current standing and prospects. Int Rev Psychiatry 25: 592-603.
  62. Frank MG, Hershman SA, Weber MD, Watkins LR, Maier SF (2014) Chronic exposure to exogenous glucocorticoids primes microglia to pro-inflammatory stimuli and induces NLRP3 mRNA in the hippocampus. Psychoneuroendocrinology 40: 191–200.
  63. Müller N, Schwarz MJ (2007) The immune-mediated alteration of serotonin and glutamate: Towards an integrated view of depression. Molecular Psychiatry 12: 988.
  64. Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacol. 31: 2121–2131.
  65. Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477-501.
  66. Swaab DF, Bao AM, Lucassen PJ (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4: 141-194.
  67. Baglietto-Vargas D, Medeiros R, Martinez-Coria H, Laferla FM, Green KN (2013) Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology. Biol Psychiatry 74: 357–366.
  68. Folstein M, Liu T, Peter I, Buell J, Arsenault L, et al. (2007) The homocysteine hypothesis of depression. Am J Psychiatry 164: 861-867.
  69. Duman RS, Malberg J, Thome J (1999) Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46: 1181-1191.
  70. Pollari E, Goldsteins G, Bart G, Koistinaho J, Giniatullin R (2014) The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front Cell Neurosci 8: 131.
Citation: Verma RK (2016) In Vivo Evaluation of the Antidepressant Activity of a Novel Polyherbal Formulation. Autism Open Access 6:194.

Copyright: © 2016 Verma RK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Top